Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Dec 01, 2022

BUY
$8.48 - $11.13 $17,511 - $22,983
2,065 Added 24.61%
10,457 $89,000
Q3 2022

Oct 31, 2022

BUY
$8.48 - $11.13 $17,511 - $22,983
2,065 Added 24.61%
10,457 $89,000
Q2 2022

Dec 01, 2022

SELL
$9.95 - $12.27 $14,686 - $18,110
-1,476 Reduced 14.96%
8,392 $88,000
Q2 2022

Aug 02, 2022

SELL
$9.95 - $12.27 $14,686 - $18,110
-1,476 Reduced 14.96%
8,392 $88,000
Q1 2022

Dec 01, 2022

SELL
$9.81 - $15.4 $27,919 - $43,828
-2,846 Reduced 22.38%
9,868 $107,000
Q1 2022

May 06, 2022

SELL
$9.81 - $15.4 $27,919 - $43,828
-2,846 Reduced 22.38%
9,868 $107,000
Q4 2021

Dec 01, 2022

SELL
$12.09 - $14.68 $40,985 - $49,765
-3,390 Reduced 21.05%
12,714 $172,000
Q4 2021

Feb 09, 2022

SELL
$12.09 - $14.68 $40,985 - $49,765
-3,390 Reduced 21.05%
12,714 $172,000
Q3 2021

Dec 01, 2022

BUY
$13.25 - $15.13 $11,289 - $12,890
852 Added 5.59%
16,104 $218,000
Q3 2021

Nov 05, 2021

BUY
$13.25 - $15.13 $11,289 - $12,890
852 Added 5.59%
16,104 $218,000
Q2 2021

Dec 01, 2022

SELL
$12.97 - $16.15 $209,893 - $261,355
-16,183 Reduced 51.48%
15,252 $218,000
Q2 2021

Aug 06, 2021

SELL
$12.97 - $16.15 $209,893 - $261,355
-16,183 Reduced 51.48%
15,252 $218,000
Q1 2021

Dec 01, 2022

SELL
$13.59 - $18.54 $284,669 - $388,357
-20,947 Reduced 39.99%
31,435 $440,000
Q1 2021

Apr 30, 2021

SELL
$13.59 - $18.54 $284,669 - $388,357
-20,947 Reduced 39.99%
31,435 $440,000
Q4 2020

Dec 01, 2022

BUY
$14.3 - $18.74 $599,527 - $785,674
41,925 Added 400.93%
52,382 $982,000
Q4 2020

Feb 03, 2021

BUY
$14.3 - $18.74 $749,062 - $981,638
52,382 New
52,382 $982,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Mufg Americas Holdings Corp Portfolio

Follow Mufg Americas Holdings Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Americas Holdings Corp with notifications on news.